TuHURA Biosciences Files 8-K with Corporate Updates
Ticker: HURA · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1498382
Sentiment: neutral
Topics: corporate-action, filing
TL;DR
TuHURA Biosciences filed an 8-K, likely with corporate updates. Keep an eye on this.
AI Summary
TuHURA Biosciences, Inc. (formerly Kintara Therapeutics, Inc.) filed an 8-K on June 27, 2025, reporting events as of June 23, 2025. The filing indicates amendments to its articles of incorporation or bylaws and includes financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Tampa, Florida.
Why It Matters
This filing signals potential changes in TuHURA Biosciences' corporate structure or governance, which could impact its strategic direction and investor relations.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.
Key Players & Entities
- TuHURA Biosciences, Inc. (company) — Registrant
- Kintara Therapeutics, Inc. (company) — Former company name
- DelMar Pharmaceuticals, Inc. (company) — Former company name
- Berry Only Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Tampa, Florida (location) — Principal executive offices
- June 23, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Filing date
FAQ
What specific amendments were made to TuHURA Biosciences' articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What is the significance of the former company names listed?
The former company names (Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.) indicate historical name changes for TuHURA Biosciences, Inc.
When was the most recent name change for the company?
The most recent name change was on August 20, 2020, when the company was formerly known as Kintara Therapeutics, Inc.
Where are TuHURA Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 10500 University Center Dr., Suite 110, Tampa, Florida 33612.
What is the Standard Industrial Classification (SIC) code for TuHURA Biosciences, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).